Sample‐size estimation is not reported in 24% of randomised controlled trials of inflammatory bowel disease: A systematic review

BACKGROUND: Sample‐size estimation is an important factor in designing a clinical trial. A recent study found that 65% of Cochrane systematic reviews had imprecise results. OBJECTIVE: This study set out to review the whole body of inflammatory bowel disease (IBD) randomised controlled trials systema...

Descripción completa

Detalles Bibliográficos
Autores principales: Iheozor‐Ejiofor, Zipporah, Lakunina, Svetlana, Gordon, Morris, Akintelure, Daniel, Sinopoulou, Vasiliki, Akobeng, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Inflammatory Bowel Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259284/
https://www.ncbi.nlm.nih.gov/pubmed/33104495
http://dx.doi.org/10.1177/2050640620967899

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259284/
https://www.ncbi.nlm.nih.gov/pubmed/33104495
http://dx.doi.org/10.1177/2050640620967899

Ejemplares similares